Previous studies have indicated a relationship between deficiencies in MMR components (MSH6, MSH2, MLH1, PMS2) and GBM recurrence [5-7]; however it remains unclear which component is most relevant for the acquisition of TMZ resistance. This evidence concerns the gene MLH1 and glioblastoma.